Effects of antidepressant drugs on sleep EEG in patients with major depression: Mechanisms and therapeutic implications

CNS Drugs

Volumn 11, Issue 1, 1999, Pages 49-60

  Staner, Luc ^a   Luthringer, Rémy ^a   Macher, Jean Paul ^a  

^a FORENAP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMINEPTINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; IPRINDOLE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; OXAPROTILINE; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE; VILOXAZINE;

DEPRESSION; ELECTROENCEPHALOGRAM; HUMAN; NONREM SLEEP; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REM SLEEP; REVIEW; SEROTONINERGIC SYSTEM; SLEEP; SLOW WAVE SLEEP;

EID: 0032930331     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199911010-00005     Document Type: Review

References (126)

1. 1. Reynolds CF III, Kupfer DJ. Sleep research in affective illness: state of the art circa 1987. Sleep 1987; 10: 199-215
2. 2. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA 1989; 162: 1479-84
3. 3. Wu JC, Bunney WE. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 1990; 147: 14-21
4. 4. Wehr TA. Sleep-loss as a possible mediator of diverse causes of mania. Br J Psychiatry 1991; 159: 576-8
5. 5. Barbini B, Bertelli S, Colombo C, et al. Sleep loss, a possible factor in augmenting manic episode. Psychiatry Res 1996; 65; 121-5
6. 6. Wirz-Justice A. Biological rhythms in mood disorder. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology, the fourth generation of progress. New York: Raven Press, 1995: 999-1017
7. 7. Lesch DR, Spire JP. Clinical electroencephalography. In: Thorpy MJ, editor. Handbook of sleep disorders. New York: Marcel Dekker Inc., 1990: 1-31
8. 8. Benca RM, Obermeyer WH, Thisted RA, et al. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 1992; 49: 651-68
9. 9. Buysse DJ, Kupfer DJ. Diagnostic and research applications of electroencephalographic sleep studies in depression: conceptual and methodological issues. J Nerv Ment Dis 1990; 178: 405-14
10. 10. Kupfer DJ, Bulik CM, Grochocinski V. Relationship between EEG sleep measures and clinical ratings of depression. J Affect Disord 1984; 6:43-52
11. 11. Hubain P, Van Veeren C, Staner L, et al. Neuroendocrine and sleep variables in major depressed inpatients: role of severity. Psychiatry Res 1996; 63: 83-92
12. 12. Kerkhofs M, Kempenaers C, Linkowski P, et al. Multivariate study of sleep EEG in depression. Acta Psychiatrica Scand 1988; 77: 463-8
13. 13. Knowles JB, McLean AW. Age-related changes in sleep in depressed and healthy subjects: a meta-analysis. Neuropsychopharmacology 1990; 3: 257-9
14. 14. Fossion P, Staner L, Dramaix M, et al. Does sleep EEG data distinguish between UP, BPI or BPII major depressions? An age and gender controlled study. J Affect Disord 1998; 49: 181-7
15. 15. Hubain P, Souery D, Jönck L, et al. Relationship between the Newcastle scale and sleep polysomnographic variables in major depression: a controlled study. Eur Neuropsychopharmacol 1995; 5: 129-34
16. 16. Stefos G, Staner L, Kerkhofs M, et al. Shortened REM latency as a psychobiologic marker for psychotic depression? An age, gender and polarity controlled study. Biol Psychiatry. In press
17. 17. Insel TR, Gillin JC, Moore A, et al. The sleep of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1982; 39: 1372-7
18. 18. Uhde TW, Roy-Byrne P, Gillin JC, et al. The sleep of patients with panic disorder. A preliminary report. Psychiatry Res 1984; 12: 251-9
19. 19. Papadimitriou GN, Kerkhofs M, Kempenaers C, et al. EEG sleep studies in patients with generalised anxiety: a preliminary comparison with depressed outpatients. Psychiatry Res 1983; 8: 81-9
20. 20. Walsch BT, Goetz R, Roose SP, et al. EEG-monitored sleep in anorexia nervosa and bulimia. Biol Psychiatry 1985; 20: 947-56
21. 21. Levy AB, Dixon KN, Schmidt H. Sleep architecture in anorexia nervosa and bulimia. Biol Psychiatry 1988; 23: 99-101
22. 22. Delvenne V, Kerkhofs M, Appelboom-Fondu J, et al. Sleep polygraphic variables in anorexia nervosa and depression: a comparative study in adolescents. J Affect Disord 1992; 25: 167-72
23. 23. Snyder S, Karacan I. Sleep patterns of sober chronic alcoholics. Neuropsychobiology 1985; 13: 97-100
24. 24. Gillin JC, Smith TL, Irwin M, et al. EEG sleep studies in 'pure' primary alcoholism during subacute withdrawal: relationship to normal controls, age, and other clinical variables. Biol Psychiatry 1990; 27: 477-88
25. 25. Le Bon O, Verbanck P, Hoffmann G, et al. Sleep in detoxified alcoholics: impairment of most standard sleep parameters and increased risk for sleep apnea, but not for myoclonias - a controlled study. J Stud Alcohol 1997; 58: 30-6
26. 26. Hiatt JF, Floyd TC, Katz PH, et al. Further evidence of abnormal non-rapid eye movement sleep in schizophrenia. Arch Gen Psychiatry 1985; 42: 797-802
27. 27. Ganguli R, Reynolds III CF, Kupfer DJ. Electroencephalographic sleep in young never-medicated schizophrenics. Arch Gen Psychiatry 1987; 44: 36-44
28. 28. Kempenaers C, Kerkhofs M, Linkowski P, et al. Sleep EEG variables in young schizophrenics and depressive patients. Biol Psychiatry 1988; 24; 828-33
29. 29. Katz JL, Kuperberg A, Pollack CP, et al. Is there a relationship between eating disorder and affective disorder? New evidence from sleep recordings. Am J Psychiatry 1984; 141: 753-9
30. 30. Moeller FG, Gillin JC, Irwin M, et al. A comparison of sleep EEGs in patients with primary major depression and major depression secondary to alcoholism. J Affect Disord 1993; 27: 39-42
31. 31. Zarcone VC, Benson KL Berger PA. Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry 1987; 44: 45-8
32. 32. Le Bon O, Staner L, Murphy JR, et al. Critical analysis of the theories advanced to explain short REM sleep latencies and other sleep anomalies in several psychiatric conditions. J Psychiatry Res 1997; 31: 433-50
33. 33. Vogel GW, Buffenstein A, Minter K, et al. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 1990; 14: 49-63
34. 34. Hartmann E. Reserpine: its effect on the sleep-dream cycle in man. Psychopharmacologia 1966; 9: 242
35. 35. Bhatti T, Gillin JC, Selfritz E, et al. Effects of a tryptophan-free amino acid drink challenge on normal human sleep electroencephalogram and sleep. Biol Psychiatry 1998; 43: 52-9
36. 36. Moore P, Gillin JC, Bhatti T, et al. Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Arch Gen Psychiatry 1998; 55: 534-9
37. 37. Hartmann E, Cravens J. The effects of long-term administration of psychotropic drugs on human sleep. III. The effects of amitriptyline. Psychopharmacologia 1974; 33: 185-202
38. 38. Passouant P, Cadhilac J, Billiard M. Withdrawal of the paradoxical sleep by clomipramine. A electrophysiological, histochemical and biochemical study. Int J Ncurol 1975; 10: 186-97
39. 39. Herdman JRE, Cowen PJ, Campling GM, et al. Effect of lofepramine on 5-HT function and sleep. J Affect Disord 1993; 29: 63-72
40. 40. Kupfer DJ, Foster FG, Reich L, et al. EEG sleep changes as predictors in depression. Am J Psychiatry 1976; 133: 622-6
41. 41. Gillin JC, Wyatt RJ, Fram D, et al. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 1978; 59: 267-72
42. 42. Mendlewicz J, Kempenaers C, De Martelaer V. Sleep EEG and amitriptyline treatment in depressed inpatients. Biol Psychiatry 1991; 30: 691-702
43. 43. Hochli D, Riemann D, Zulley J, et al. Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with major depressive disorder. Biol Psychiatry 1986; 21: 1217-20
44. 44. Kupfer DJ, Ehlers CL, Pollock BJ, et al. Clomipramine and EEG sleep in depression. Psychiatry Res 1989; 30: 165-80
45. 45. Chen CN. Sleep, depression and antidepressants. Br J Psychiatry 1979; 135: 385-402
46. 46. Kupfer DJ, Coble P, Kane J, et al. Imipramine and EEG sleep in children with depressive symptoms. Psychopharmacology 1979; 60: 117-23
47. 47. Kupfer DJ, Spiker DJ, Rossi A, et al. Nortriptyline and EEG sleep in depressed patients. Biol Psychiatry 1982; 7: 535-46
48. 48. Wiegand M, Berger M, Zulley J, et al. The effect of trimipramine on sleep in patients with major depressive disorder. Pharmacopsychiatry 1986; 19: 198-9
49. 49. Ware JC, Brown FW, Moorad PJ Jr, et al. Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients. Sleep 1989; 12: 537-49
50. 50. Feuillade P, Pringuey D, Belogou JL, et al. Trimipramine: acute and lasting effects on sleep in healthy and major depressive subjects. J Affect Disord 1992; 24: 135-46
51. 51. Baxter BL, Gluckman MI. Iprindole: an antidepressant which does not block REM sleep. Nature 1969; 223: 750-2
52. 52. Blackburn AB, Karacan I, Salis PJ, et al. The effects of doxepin HCl on sleep patterns of neurotically depressed patients with sleep disturbances [abstract]. Sleep Res 1975; 4: 90
53. 53. Roth T, Zorick F, Wittig R, et al. The effect of doxepine HCl on sleep and depression. J Clin Psychiatry 1982; 43: 366-8
54. 54. Shipley JE, Kupfer DJ, Griffin SJ, et al. Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients. Psychopharmacology 1985; 85: 14-22
55. 55. Kupfer DJ, Perel JM, Pollock BG, et al. Fluvoxamine versus desipramine: comparative polysomnographic effects. Biol Psychiatry 1991; 29: 23-40
56. 56. Luthringer R, Toussaint M, Schaltenbrand N, et al. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharm Bull 1996; 32: 637-46
57. 57. Ruigt GS, Kemp B, Groenhout CM, et al. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 1990; 38: 551-4
58. 58. Wyatt RJ, Fram DH, Kupfer DJ. Total prolonged drug-induced REM sleep suppression in anxious-depressive patients. Arch Gen Psychiatry 1971; 24: 145-55
59. 59. Kupfer DJ, Bowers MB Jr. REM sleep and central monoamine oxidase inhibitions. Psychopharmacologia 1972; 27: 18.3-90
60. 60. Cohen RM, Pickar D, Garnett, et al. REM sleep suppression induced by selective monoamine oxidase inhibitors. Psychopharmacology 1982; 78: 137-40
61. 61. Monti JM, Alterwain P, Monti D. The effects of moclobemide on nocturnal sleep of depressed patients. J Affect Disord 1990; 20: 201-8
62. 62. Minot R, Luthringer R, Macher JP. Effect of moclobemide on the psychophysiology of sleep/wake cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide. Int Clin Psychopharmacol 1993; 7: 181-9
63. 63. Minot R, Luthringer R, Toussaint M, et al. Sleep/wake study of a selective IMAO antidepressant: toloxatone [abstract]. Biol Psychiatry 1991; 29: 100
64. 64. Nicholson AN, Pascoe PA. 5-hydroxytryptamine and noradrenaline uptake inhibitions. Studies on sleep in man. Neuropharmacology 1986; 25: 1079-83
65. 65. Saletu B, Frey R, Krupka M, et al. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep 1991; 14: 439-47
66. 66. Brezinova V, Adam K, Chapman K, et al. Viloxazine, sleep and subjective feelings. Psychopharmacology 1977; 55: 121-8
67. 67. Shipley JE, Kupfer DJ, Dealy RS, et al. Differential effects of zimelidine on the sleep electroencephalogram of depressed patients. Clin Pharmacol Ther 1984; 36: 251-9
68. 68. Berger M, Emrich HM, Lund D, et al. Sleep EEG variables as course criteria and predictors of antidepressant therapy with fluvoxamine/oxaprotiline. Adv Pharmacother 1986; 2: 110-20
69. 69. Kerkhofs M, Rielaert C, De Martelaer V, et al. Fluoxetine in major depression: efficacy, safety and effects on sleep EEG variables. Int Clin Psychopharmacol 1990; 5: 253-60
70. 70. Van Bemmel AL, Beersma DGM, Van Den Hoofdakker RH. Changes in EEG power density of NREM sleep in depressed patients during treatment with citalopram. J Sleep Res 1993; 2: 156-62
71. 71. Staner L, Kerkhofs M, Detroux D, et al. Acute, subchronic, and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep 1995; 18: 470-7
72. 72. Montgomery SA, Bullock T, Pinder RM. The clinical profile of mianserine. Nord Psykiatr Tidsskr 1991; 45: 24-35
73. 73. Tormey WP, Buckley MP, O'Kelly DA, et al. A Sleep-endocrine profile of the antidepressant mianserin. Curr Med Res Opin 1980; 6: 456-60
74. 74. Mendlewicz J, Dunbar GC, Hoffman G. Changes in sleep EEG architecture during the treatment of depressed patients with mianserine. Acta Psychiatrica Scand 1985; Suppl. 320: 26-9
75. 75. Brodgen RN, Heel RC. Speight TM, et al. Trazodone: a review of its pharmacologic properties and therapeutic use in depression and anxiety. Drugs 1981; 21: 401-29
76. 76. Montgomery I, Oswald I, Morgan K, et al. Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol 1983; 16: 139-44
77. 77. Ware JC, Rose FV, McBrayer RH. The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects. Sleep 1994; 17: 544-50
78. 78. Van Bemmel AL, Havermans RG, van Diest R. Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology 1992; 107: 569-74
79. 79. Parrino L, Spaggiari MC, Boselli M, et al. Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia. Psychopharmacology 1994; 116: 389-95
80. 80. Mouret J, Lemoine P, Minuit MP, et al. Effects of trazodone on the sleep of depressed subjects - a polygraphic study. Psychopharmacology 1988; 95: S37-S43
81. 81. Scharf MB, Sachais B A. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J Clin Psychiatry 1990; 51 Suppl.: 13-7
82. 82. Taylor DP, Carter RB, Eison AS, et al. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatry 1995; 56 Suppl. 6: 3-11
83. 83. Vogel G, Cohen J, Mullis D, et al. Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep? Sleep 1998; 21: 70-7
84. 84. Sharpley AL, Williamson DJ, Attenburrow ME, et al. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 1996; 126: 50-4
85. 85. Armitage R, Rush AJ, Trivedi M, et al. The effects of nefazodone on sleep on sleep architecture in depression. Neuropsychopharmacology 1994; 10: 123-7
86. 86. Rush JA, Armitage R, Gillin JC, et al. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depression. Biol Psychiatry 1998; 44: 3-14
87. 87. Nofzinger EA, Reynolds CF III, Thase ME, et al. REM sleep enhancement by bupropion in depressed man. Am J Psychiatry 1995; 152: 274-6
88. 88. Ferris RM, Cooper BR. Mechanism of antidepressant activity of bupropion. J Clin Psychiatry Monogr 1993; 11: 2-14
89. 89. Di Perri R, Mailland F, Bramanti P. The effects of amineptine on mood and nocturnal sleep of depressed patients. Progr Neuropsychopharm Biol Psychiatry 1986; 11: 65-70
90. 90. Macher JP, Luthringer R, Toussaint M, et al. Brain mapping and psychoactive drugs. In: Hindmarch I, Stonier PD, editors. Human psychopharmacology: methods and measures. Vol 3. New York: John Wiley & Sons, 1990: 1-20
91. 91. Staner L, Mendlewicz J. Effect of a single dose of tianeptine in healthy volunteer on sleep electrophysiological parameters [abstract]. Eur Psychiatry [994; 9 Suppl. 1: 141
92. 92. Macher JP, Minot R, Duval F, et al. Neuro-electrophysiologic studies in abstinent and depressed alcoholic patients treated with tianeptine. Presse Med 1991; 20: 1853-7
93. 93. Hobson AJ, Stickgold R, Pare-Schott EF. The neuropsychology of REM sleep dreaming. Neuroreport 1998; 9: R1-R14
94. 94. McCarley RW. REM sleep and depression: common neurobiological control mechanisms. Am J Psychiatry 1982; 139: 565-70
95. 95. Gillin JC, Sitaram N, Mendelsohn WB. Acetylcholine, sleep and depression. Hum Neurobiol 1982; 1: 211-9
96. 96. Schittecatte M, Charles G, Machowski R, et al. Reduced clonidine rapid eye movement sleep suppression in patients with primary affective illness. Arch Gen Psychiatry 1992; 49: 637-42
97. 97. Seeman R. Receptor tables vol 2: dissociation constants for neuroreceptors and transporters. Toronto: SZ Research, 1993
98. 98. Rye DB. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep 1997; 20: 757-88
99. 1A agonist, on sleep pattern of healthy subjects. Psychopharmacology 1995; 117: 186-92
100. 1A agonist in normal volunteers. Psychopharmacology 1994; 116: 433-6
101. 101. Tissier MH, Lainey E, Fattaccini CM, et al. Effects of ipsapirone, a 5-HT1A agonist on sleep/wakefulness cycles: probably a post-synaptic action. J Sleep Res 1993; 2: 103-9
102. 102. Maes M, Meltzer HY. The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology, the fourth generation of progress. New York: Raven Press, 1995: 933-44
103. 103. Kupfer DJ, Ehlers CL, Franck E, et al. Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment. Biol Psychiatry 1994; 35: 781-93
104. 104. Kupfer DJ, Shipley JE, Perel JM, et al. Antidepressants and sleep EEG: Search for specificity. In: Dahl SG, Gram LF, Paul SM, et al., editors. Clinical pharmacology in psychiatry: selectivity in psychotropic drugs action - promises or problems? New York: Springer-Verlag, 1987: 167-73
105. 105. Reynolds CF III, Hoch CC, Buysse DJ, et al. Sleep in late-life recurrent depression: changes during early continuation therapy with nortriptyline. Neuropsychopharmacology 1991; 5: 85-96
106. 106. Reynolds CF III, Buysse DJ, Brunner D, et al. Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo-and plasma-level-controlled evaluation. Biol Psychiatry 1997; 42: 560-7
107. 107. Röschke J, Kögel P, Schlössser R, et al. Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects. Psychopharmacology 1997; 132: 44-7
108. 108. Van Bemmel AL, Beersma DGM, Van Den Hoofdakker RH. Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone. J Affect Disord 1995; 35: 11-9
109. 2C receptors. Neuropharmacology 1994; 13: 467-71
110. 110. Idzikowski C, Mills FJ, Glennard R. 5-hydroxytamine-2 antagonist increases human slow wave sleep. Brain Res 1986; 378: 164-8
111. 111. Sharpley AL, Solomon RA, Fernando AI, et al. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology 1990; 101: 568-9
112. 112. Brandenberger G, Luthringer R, Muller G, et al. 5-HT2 receptors are partially involved in the relationship between renin release and relative deita power. J Endocrinol Invest 1996; 19: 556-62
113. 113. Staner L, Kempenaers C, Simonnet MP, et al. 5-HT2 receptor antagonism and slow wave sleep in major depression. Acta Psychiatr Scand 1992; 86: 133-7
114. 114. Katsuda Y, Walch AE, Ware CJ, et al. Meta-chlorophenylpiperazine decreases slow wave sleep in humans. Biol Psychiatry 1993; 33: 49-51
115. 115. Kupfer DJ, Pollock BG, Perel JM, et al. Effect of pulse loading with clomipramine on EEG sleep. Psychiatry Res 1994; 54: 161-75
116. 116. Bauer J, Hohagen F, Gimmel E, et al. Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol Psychiatry 1995; 38: 611-21
117. 117. Thase ME, Simons AD, Reynolds CF III. Abnormal electroencephalographic sleep profiles in major depression. Association with response to cognitive behavior therapy. Arch Gen Psychiatry 1996; 53: 99-108
118. 118. Thase ME, Buysse DJ, Frank E, et al. Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles. Am J Psychiatry 1997; 154: 502-9
119. 119. Luthringer R, Minot R, Toussaint M, et al. All-night spectral analysis as a tool for the prediction of clinical response to antidepressant treatment. Biol Psychiatry 1995; 38: 98-104
120. 120. Ehlers CL, Havstad JW, Kupfer DJ. Estimation of time course of slow-wave sleep over the night in depressed patients: effects of clomipramine and clinical response. Br J Psychiatry 1996; 39: 171-81
121. 121. Neylan TC. Treatment of sleep disturbances in depressed patients. J Clin Psychiatry 1995; 56 Suppl. 2: 56-61
122. 122. Borbely AA, Akersiedt T, Benoit O, et al. Hypnotics and sleep physiology: a consensus report. Eur Arch Psychiatry Clin Neurosci 1991; 241: 13-21
123. 123. Buysse DJ, Frank E, Lowe KK, et al. Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol Psychiatry 1997; 41: 406-18
124. 124. Steriade M, McCormick DA, Sejnowski TJ. Thalamocortical oscillations in the sleeping and aroused brain. Science 1993; 262: 679-85
125. 125. Armitage R. Microarchitectural findings in sleep EEG in depression: diagnostic implications. Biol Psychiatry 1995; 37: 72-84
126. 126. Armitage R, Roffwarg H, Rush A, et al. Digital period analysis of EEG in depression: periodicity, coherence, and interhemispheric relationships during sleep. Prog Neuropsychopharmacol Biol Psychiatry. 1993; 17: 363-72